A phase 1b dose-escalation and dose-expansion study of e

  • Rao, Arpit (PI)
  • Gupta, Shilpa (Prior Principal Investigator)

Project: Research project

Project Details

Description

A phase 1b dose-escalation and dose-expansion study of enfortumab vedotin (ASG-22CE) in combination with immune checkpoint inhibitor (CPI) therapy for treatment of patients with locally advanced or metastatic urothelial cancer
StatusActive
Effective start/end date12/1/172/28/21

Funding

  • Seattle Genetics, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.